These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28410602)
1. Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient. Banerjee I; De Leon D; Dunne MJ Orphanet J Rare Dis; 2017 Apr; 12(1):70. PubMed ID: 28410602 [TBL] [Abstract][Full Text] [Related]
2. Morphoproteomics and biomedical analytics coincide with clinical outcomes in supporting a constant but variable role for the mTOR pathway in the biology of congenital hyperinsulinism of infancy. Brown RE; Senniappan S; Hussain K; McGuire MF Orphanet J Rare Dis; 2017 Dec; 12(1):181. PubMed ID: 29246172 [TBL] [Abstract][Full Text] [Related]
3. The Effectiveness of Sirolimus Treatment in Two Rare Disorders with Nonketotic Hypoinsulinemic Hypoglycemia: The Role of mTOR Pathway. Şıklar Z; Çetin T; Çakar N; Berberoğlu M J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):439-443. PubMed ID: 32157856 [TBL] [Abstract][Full Text] [Related]
4. Sirolimus in severe hyperinsulinemic hypoglycemia. Mao S; Zhang A; Huang S N Engl J Med; 2014 Jun; 370(25):2448. PubMed ID: 24941188 [No Abstract] [Full Text] [Related]
5. Sirolimus in infants with congenital hyperinsulinism (CHI) - a single-centre experience. Panigrahy N; Chirla DK; Bagga N; Gunda RK; Sukhija B; Reddy L Eur J Pediatr; 2022 Jan; 181(1):407-412. PubMed ID: 34304300 [TBL] [Abstract][Full Text] [Related]
6. Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia. Senniappan S; Alexandrescu S; Tatevian N; Shah P; Arya V; Flanagan S; Ellard S; Rampling D; Ashworth M; Brown RE; Hussain K N Engl J Med; 2014 Mar; 370(12):1131-7. PubMed ID: 24645945 [TBL] [Abstract][Full Text] [Related]
7. mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic Success. Szymanowski M; Estebanez MS; Padidela R; Han B; Mosinska K; Stevens A; Damaj L; Pihan-Le Bars F; Lascouts E; Reynaud R; Ferreira C; Bansept C; de Lonlay P; Saint-Martin C; Dunne MJ; Banerjee I; Arnoux JB J Clin Endocrinol Metab; 2016 Dec; 101(12):4719-4729. PubMed ID: 27691052 [TBL] [Abstract][Full Text] [Related]
8. Sirolimus in severe hyperinsulinemic hypoglycemia. Senniappan S; Brown RE; Hussain K N Engl J Med; 2014 Jun; 370(25):2448-9. PubMed ID: 24941187 [No Abstract] [Full Text] [Related]
9. Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia. Abraham MB; Shetty VB; Price G; Smith N; Bock Md; Siafarikas A; Resnick S; Whan E; Ellard S; Flanagan SE; Davis EA; Jones TW; Hussain K; Choong CS J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1391-8. PubMed ID: 26226122 [TBL] [Abstract][Full Text] [Related]
10. Sirolimus therapy for congenital hyperinsulinism in an infant with a novel homozygous KCNJ11 mutation. Korula S; Chapla A; Priyambada L; Mathai S; Simon A J Pediatr Endocrinol Metab; 2018 Jan; 31(1):87-89. PubMed ID: 29176012 [TBL] [Abstract][Full Text] [Related]
11. A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus. Ünal S; Gönülal D; Uçaktürk A; Siyah Bilgin B; Flanagan SE; Gürbüz F; Tayfun M; Elmaoğulları S; Araslı A; Demirel F; Ellard S; Hussain K J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):478-481. PubMed ID: 27181099 [TBL] [Abstract][Full Text] [Related]
12. Severe Hyperinsulinemic Hypoglycemia in a Neonate: Response to Sirolimus Therapy. Méder Ü; Bokodi G; Balogh L; Körner A; Szabó M; Pruhova S; Szabó AJ Pediatrics; 2015 Nov; 136(5):e1369-72. PubMed ID: 26504129 [TBL] [Abstract][Full Text] [Related]
13. Effective and safe use of sirolimus in hyperinsulinemic hypoglycaemia refractory to medical and surgical therapy: a case series and review of literature. Burnside MJ; Benitez-Aguirre P; Romans R; Gehrmann F; Velayutham V; Alexander A; Choong CS; Abraham MB J Pediatr Endocrinol Metab; 2024 Oct; 37(10):900-911. PubMed ID: 39190903 [TBL] [Abstract][Full Text] [Related]
14. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation. Shah P; Arya VB; Flanagan SE; Morgan K; Ellard S; Senniappan S; Hussain K J Pediatr Endocrinol Metab; 2015 May; 28(5-6):695-9. PubMed ID: 25518065 [TBL] [Abstract][Full Text] [Related]
15. Sirolimus Therapy in Congenital Hyperinsulinism: A Successful Experience Beyond Infancy. Minute M; Patti G; Tornese G; Faleschini E; Zuiani C; Ventura A Pediatrics; 2015 Nov; 136(5):e1373-6. PubMed ID: 26504125 [TBL] [Abstract][Full Text] [Related]
16. Sirolimus Therapy and Follow-up in a Patient with Severe Congenital Hyperinsulinism Following Subtotal Pancreatectomy. Chen Q; Chen Y; Wang X; Yang H; Zhang Y; Liu X; Yan Y; Wei H J Clin Res Pediatr Endocrinol; 2021 Feb; 13(1):119-123. PubMed ID: 32482020 [TBL] [Abstract][Full Text] [Related]
17. Response to sirolimus in a case of diffuse congenital hyperinsulinaemic hypoglycaemia due to homozygous Oza CM; Khadilkar V; Kadam S; Khadilkar A BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36410788 [TBL] [Abstract][Full Text] [Related]
18. Low-dose diazoxide therapy in hyperinsulinaemic hypoglycaemia. Ng AY; Agrawal P; Vijayan R; Arya VB; Kapoor RR; Shah P Clin Endocrinol (Oxf); 2024 Feb; 100(2):140-142. PubMed ID: 38059613 [No Abstract] [Full Text] [Related]
19. [Pitfalls in the diagnosis of congenital hyperinsulinism: a case report and review of the literature]. Fernandez Alvarez JR; Rabe H; Wilichowski E; Pekrun A Klin Padiatr; 2006; 218(4):233-6. PubMed ID: 16819706 [TBL] [Abstract][Full Text] [Related]
20. Ketotic hypoglycaemia in children with diazoxide responsive hyperinsulinism of infancy. Hussain K Eur J Pediatr; 2005 Jun; 164(6):387-90. PubMed ID: 15772812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]